548 Avsnitt

  1. Overcoming a Delivery Challenge of Retinal Gene Therapies

    Publicerades: 2025-06-19
  2. A Gene Editing First Augurs an Era of Bespoke Therapies

    Publicerades: 2025-06-12
  3. How One Patient Organization Drives Drug Development

    Publicerades: 2025-06-05
  4. Using CRISPR to Modulate Gene Expression

    Publicerades: 2025-05-29
  5. Satisfying the Hunger for a Prader-Willi Therapy

    Publicerades: 2025-05-22
  6. How an Academic Medical Center Helped Change the Landscape for a Rare Disease

    Publicerades: 2025-05-15
  7. Improving Outcomes for People with a Set of Rare Cancers

    Publicerades: 2025-05-08
  8. An Effort to Build a Better DMD Gene Therapy

    Publicerades: 2025-05-02
  9. A Once-Failed Pain Therapy Shows Potential in a Neurodevelopmental Disorder

    Publicerades: 2025-04-24
  10. Advancing a Cutting-Edge Therapy for a Rare, Childhood Cancer

    Publicerades: 2025-04-17
  11. Learning to Take His Vitamins

    Publicerades: 2025-04-10
  12. The First Treatment for a Rare Neurodegenerative Condition Awaits FDA Approval

    Publicerades: 2025-04-03
  13. Engineering Skin Bacteria to Be Live Biotherapeutics

    Publicerades: 2025-03-27
  14. Seeing the Gene and Cell Therapy Translational Divide as an Opportunity

    Publicerades: 2025-03-20
  15. My Mother, Myself, and ALS

    Publicerades: 2025-03-13
  16. From Immovable Object to Advocacy Force

    Publicerades: 2025-03-06
  17. A Rapid and Scalable Approach for Screening Personalized ASOs

    Publicerades: 2025-02-27
  18. Addressing the Disease Mechanism of a Rare Kidney Disease

    Publicerades: 2025-02-20
  19. The Mother of a Son with SCD, Applies Direct Experience to Her Clinical Trials Work

    Publicerades: 2025-02-13
  20. A First for Rett Syndrome with More in the Pipeline

    Publicerades: 2025-02-06

1 / 28

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Visit the podcast's native language site